EML4-ALK Fusion in Lung

被引：13
|
作者：
Mano, Hiroyuki [1 ]
Takeuchi, Kengo [2 ]
机构：
[1] Univ Tokyo, Tokyo, Japan
[2] Japanese Fdn Canc Res, Inst Canc, Tokyo 170, Japan
来源：
AMERICAN JOURNAL OF PATHOLOGY | 2010年 / 176卷 / 03期
关键词：
CANCER; IDENTIFICATION; TISSUES; GENE;
D O I：
10.2353/ajpath.2010.091057
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：1552 / 1553
页数：2
相关论文
共 50 条
  • [31] The Prevalence of the EML4-ALK Fusion Gene in Cytology Specimens from Patients with Lung Adenocarcinoma
    Heriyanto, Didik S.
    Trisnawati, Ika
    Kumara, Evan G.
    Laiman, Vincent
    Yuliani, Fara S.
    Sumpono, Auliya S. B.
    Cempaka, Rita
    Marcellus
    Budiono, Eko
    PULMONARY MEDICINE, 2020, 2020
  • [32] Synergistic effects of crizotinib and radiotherapy in experimental EML4-ALK fusion positive lung cancer
    Dai, Ying
    Wei, Quanxiang
    Schwager, Christian
    Moustafa, Mahmoud
    Zhou, Cheng
    Lipson, Kenneth E.
    Weichert, Wilko
    Debus, Juergen
    Abdollahi, Amir
    RADIOTHERAPY AND ONCOLOGY, 2015, 114 (02) : 173 - 181
  • [33] Analysis of EML4-ALK fusion transcripts in plasma and platelets to monitor response to crizotinib in EML4-ALK positive non-small cell lung cancer patients (NSCLC)
    Aguado, Cristina
    Teixido, Cristina
    Gimenez-Capitan, Ana
    Gil, Maria de los Llanos
    Rodriguez, Sonia
    Viteri, Santiago
    Karachaliou, Niki
    Aldeguer, Erika
    Peg, Vicente
    Alonso, Lidia
    Molina-Vila, Miguel Angel
    Rosell, Rafael
    CANCER RESEARCH, 2017, 77
  • [34] Novel NLRC4-ALK and EML4-ALK double fusion mutations in a lung adenocarcinoma patient: A case report
    Wu, Xueqian
    Wang, Weiya
    Zou, Bingwen
    Li, Yanying
    Yang, Xiaojuan
    Liu, Ning
    Ma, Qizhi
    Zhang, Xiaoxuan
    Wang, Yongsheng
    Li, Dan
    THORACIC CANCER, 2020, 11 (06) : 1695 - 1698
  • [35] Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants
    Heuckmann, Johannes M.
    Balke-Want, Hyatt
    Malchers, Florian
    Peifer, Martin
    Sos, Martin L.
    Koker, Mirjam
    Meder, Lydia
    Lovly, Christine M.
    Heukamp, Lukas C.
    Pao, William
    Kueppers, Ralf
    Thomas, Roman K.
    CLINICAL CANCER RESEARCH, 2012, 18 (17) : 4682 - 4690
  • [36] EML4-ALK fusion transcript is not found in gastrointestinal and breast cancers
    Fukuyoshi, Y.
    Inoue, H.
    Kita, Y.
    Utsunomiya, T.
    Ishida, T.
    Mori, M.
    BRITISH JOURNAL OF CANCER, 2008, 98 (09) : 1536 - 1539
  • [37] Malignant pleural mesothelioma with an EML4-ALK fusion: Expect the unexpected!
    Cordier, Fleur
    Van der Meulen, Joni
    van Roy, Nadine
    De Wilde, Jilke
    van Dijck, Herwig
    Vanhoenacker, Filip
    Lambrechts, Marc
    Noyez, Valentin
    Van de Vijver, Koen
    Ferdinande, Liesbeth
    Dendooven, Amelie
    Van Dorpe, Jo
    Creytens, David
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 231
  • [38] Small cell lung cancer with EML4-ALK fusion: report of a case responding to ALK TKI and literature review
    Wang, Mingyue
    Liu, Hongzhi
    Zhang, Ruixin
    Li, Runyu
    Qin, Xiaoyu
    Ning, Fangling
    Tian, Lijun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2025, 151 (02)
  • [39] Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively
    Hong Tao
    Zhe Liu
    Jing Mu
    Fei Gai
    Zhan Huang
    Liang Shi
    Diagnostic Pathology, 17
  • [40] Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively
    Tao, Hong
    Liu, Zhe
    Mu, Jing
    Gai, Fei
    Huang, Zhan
    Shi, Liang
    DIAGNOSTIC PATHOLOGY, 2022, 17 (01)
12345